Vendor 1
IktosDrug Discovery Platforms
Generative AI platform for de novo drug design that accelerates medicinal chemistry projects.
Contact salesPriceNo reviewsRating2016Founded
Iktos vs PostEra
Vendor decision canvas
Vendor 2
PostEraDrug Discovery Platforms
AI-powered medicinal chemistry platform that accelerates drug design through synthesis-aware generative chemistry and retrosynthesis.
Contact salesPriceNo reviewsRating2019Founded
Carry this decision forward
Iktos + PostEra can move into a shared evaluation.
Evidence sheet
2-vendor view| Vendor 1 Iktos Drug Discovery Platforms Drug Discovery as it will be | Vendor 2 PostEra Drug Discovery Platforms Medicinal Chemistry Powered by Machine Learning | |
|---|---|---|
| Overview | ||
| Category | Drug Discovery Platforms | Drug Discovery Platforms |
| What it is | Generative AI platform for de novo drug design that accelerates medicinal chemistry projects. | AI-powered medicinal chemistry platform that accelerates drug design through synthesis-aware generative chemistry and retrosynthesis. |
| Pricing | ||
| Price | Contact sales | Contact sales |
| Pricing model | Custom quote | Custom quote |
| Free options | No free plan, No free trial | No free plan, No free trial |
| Company | ||
| Founded | 2016 | 2019 |
| Team size | 51-200 employees | 51-200 employees |
| Headquarters | Paris, France | Boston, MA |
